Iodine (125I) CC49
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | TAG-72 |
| Clinical data | |
| ATC code | |
| Identifiers | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}} |
| (verify) | |
Iodine (125I) CC49 is an iodine-125 radiolabelled monoclonal antibody for the detection of tumours. It is used in radioimmunoassays such as CA 72-4.[1]
CC49 has also been tested for the treatment of solid tumours, but without success. Iodine (131I) CC49 and lutetium (177Lu) CC49, for example, were shown to induce human anti-mouse antibodies; no tumour response was observed in Phase I and II clinical trials.[2]
Derivatives[edit]
A wide range of CC49 derivatives has been used in pharmaceutical research. Examples include chimeric[2] and humanized CC49,[3] as well as a fusion protein of a CC49 single-chain variable fragment and the enzyme beta-lactamase.[4]
References[edit]
- ↑ Guadagni, F.; Roselli, M.; Cosimelli, M.; Spila, A.; Cavaliere, F.; Tedesco, M.; Arcuri, R.; Abbolito, M. R.; Casale, V.; Pericoli, M. N.; Vecchione, A.; Casciani, C. U.; Greiner, J. W.; Schlom, J. (1996). "Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay". Cancer Research. 56 (22): 5293–5298. PMID 8912871.
- ↑ 2.0 2.1 Trahan Rieger, Paula, ed. (2001). Biotherapy (2nd ed.). Jones and Bartlett. pp. 334–335. ISBN 0-7637-1428-3. Search this book on
- ↑ Milenic, D. E.; Brady, E. D.; Garmestani, K.; Albert, P. S.; Abdulla, A.; Brechbiel, M. W. (2010). "Improved efficacy of α-particle-targeted radiation therapy". Cancer. 116 (4 Suppl): 1059–1066. doi:10.1002/cncr.24793. PMID 20127951.
- ↑ Alderson, R. F.; Toki, B. E.; Roberge, M.; Geng, W.; Basler, J.; Chin, R.; Liu, A.; Ueda, R.; Hodges, D.; Escandon, E.; Chen, T.; Kanavarioti, T.; Babé, L.; Senter, P. D.; Fox, J. A.; Schellenberger, V. (2006). "Characterization of a CC49-Based Single-Chain Fragment−β-Lactamase Fusion Protein for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)". Bioconjugate Chemistry. 17 (2): 410–418. doi:10.1021/bc0503521. PMID 16536473.
 | This monoclonal antibody–related article is a stub. You can help EverybodyWiki by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help EverybodyWiki by expanding it. |
This article "Iodine (125I) CC49" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
